Aim: We aimed to document the prevalence of misunderstanding in cancer patients and investigate whether patient denial is related to misunderstanding.
Introduction .
Many cancer patients now desire to be fully informed about their illness and to participate in treatment decision making [1, 2] . As such, shared medical decision making between doctors and patients is now commonly favoured over the traditional paternalistic approach [3, 4] .
Patients with cancer require an adequate understanding of their disease and the potential consequences of treatment to be informed participants in clinical decision making. However, there are indications that many patients do not understand information such as the extent of their disease and the likelihood of treatment achieving its goals. In 1988, Mackillop et al. [5] reported that one third of patients with metastatic disease believed it was localised and one third of those receiving palliative treatment thought that their treatment was curative in intent. Only 37% accurately cited the probability that treatment would cure their illness with more than half overestimating their chances for cure. Other studies confirm misunderstanding in cancer patients [6, 7] , suggesting that misunderstanding negatively influences patient outcomes [8] .
There may be several explanations for patient misunderstanding. For example, oncologists may withhold information or fail to communicate it clearly. An Italian study examining doctor self-reports of information provided to breast cancer patients found that less thorough information was disclosed to those who had fewer than six years of formal education, were older than 50 years of age or who had a poor prognosis [9] . In a study of audiotaped consultations between an oncologist and 146 patients, the doctor was more likely to discuss prognostic information with patients who were female or had metastatic disease [10] . Furthermore, a significant number of patients complain that clinicians do not adequately provide information or communicate it clearly [11] .
However, audiotaped records of oncology consultations demonstrate that patient misunderstanding occurs even when doctors provide information [6, 12] . These finding have lead researchers to speculate that the psychological mechanism of denial may act to selectively screen out news perceived as threatening [5, 6] . To date, however, this hypothesis has not been empirically tested. If misunderstanding is due to denial rather than poor communication, then vigorous attempts to improve the clarity and completeness of doctors' communication may be ineffective, misguided and possibly harmful.
This study sought to replicate Mackillop et al.'s study [5] almost a decade later and assess the extent of and reasons for misunderstanding in a sample of contemporary cancer patients. We specifically aimed to test the hypothesis that patient denial impedes understanding.
Patients and methods

Participant selection
Consecutive adult outpatients receiving radiotherapy or chemotherapy at a major teaching hospital in Australia, were invited to participate in the study. Patients who were physically or cognitively impaired were excluded. Non-English speaking patients were recruited if translating services were available. A research assistant administered a face-toface semi-structured interview to patients assessing their level of denial and understanding. These data were collected before patients received their second treatment dose because it was believed that by this time patients should have received all relevant medical information about their disease and would have overcome the initial anxiety associated with commencing treatment. Approval for the study was granted by the institutional ethics committee.
Assessment of denial
Denial was evaluated using the eight-item Cardiac Denial of Impact Scale [13] developed using patients with cardio-vascular disease. The scale has confirmed test re-test reliability (r = 0.71) and criterion, construct and discriminant validity [13] . Two of the items in the scale were adapted for use in this study by replacing the words 'heart disease' with the word 'cancer'. In this context, the scale measured the extent to which patients minimise the emotional impact of having cancer and deny feeling worried or afraid. Patients indicated their level of agreement on a five point scale (agree completely to disagree completely) to each of the eight items yielding a total score ranging from eight (minimal denial) to 40 (maximal denial)
Assessment of understanding
Seven items assessing patient understanding were administered after denial had been assessed. The respondents reported their diagnosis and were asked about the extent of their disease, the goal and types of treatment they were receiving and the probability that treatment would result in cure, prolongation of life and, if relevant, palliation. These probabilities were estimated as 0%, l%-25%, 26%-50%, 51%-75%, or 76%-100%. A'don't know'option was offered for each question.
Patients also rated the clarity of information received from the oncologist (very clear to very confusing), identified sources from which information perceived as useful was obtained and indicated whether they had seen another doctor since last consulting their treating oncologist.
Doctor questionnaire
Oncologists provided the 'facts' which matched the patient items, indicated whether patients had been told these facts and whether they could accurately report these details. Both the doctor and patient surveys of understanding were modelled on Mackillop et al.'s [5] questionnaires to ensure comparability between findings. Medical records were reviewed to determine the time interval in days between patients receiving information and completing the interview.
Statistics
Analyses were conducted using SPSS (V6.I for Windows). Percentage counts and 95% confidence intervals were calculated to assess the extent of patient misunderstanding and doctors' ability to perceive it. Variables listed in Table 1 were assessed for univariate association with understanding of each fact. Each fact was considered separately because our previous research has shown that doctors do not spend equal amounts of time discussing aspects of a patient's disease, treatment and expected outcomes of treatment and that patients, on average, do 102 (42) 142 (58) 178 (73) 65 (27) 82 (34) 91 (37) 39 (16) 31 (13) 174 (71) 70 (28) 210 (86) 20 (8) 14 (6) 63 (26) 35 (14) 28 (12) 26 (11) 22 (9) 21 (9) 12 (5) 11 (5) 26 (11) 59 (25) 77 (32) 20 (8) 12 (5) 72 (30) 23 (9) 43 (18) 48 (20) 48 (20) 34 (14) 44 (18) 59 (24) (9) 110 (45) 92 (38) 22 (9) 13 (5) 3 (1) 4 (2) Item" Loading 1 Ninety-nine patients (41%) cited more than one 'useful' source.
not express an equivalent need to know each of these facts [2, 10] . Therefore, patient understanding and predictors were expected to vary for the different facts and Bonferroni adjustments in this context were not considered appropriate [14] . In addition, patient denial, whether patients nominated more than one source of useful information and had seen another doctor seen last consulting their oncologist, doctors' disclosure of information and the time interval between patients receiving information and completing the interview were assessed for associations with understanding. The effect of individual oncologists on understanding was also explored. Variables demonstrating a univariate association with the outcomes (P < 0.25, [15] ) were modelled in multiple logistic regression analyses. Categorical variables were created from the continuous variables using quartile cut-off points and were modelled as continuous only if a significant linear association was demonstrated according to the Mantel-Haenszel chi-square statistic (P < 0.05) and if the odds ratios derived from univariate logistic regression analyses were ordered across the categories. If no linear association was evident, variables were dichotomised according to a median split to maximise the power of the analysis [15] . A backward elimination procedure with a criterion of P < 0.05 was used to select significant predictors. Principle components factor analysis using varimax rotation determined the factor structure of the Cardiac Denial of Impact Scale [16] . The internal consistency of the measure was evaluated using Cronbach's alpha. Multiple logistic regression analyses were used to explore the construct validity of the denial scale.
Results
The sample comprised 118 and 126 outpatients who saw one of five medical or five radiation oncologists, respectively. Five patients refused their participation (2%). All full-time medical and radiation oncologists employed at the hospital were involved in the study. Eight of the clinicians were male and two of the radiation oncologists were junior staff. A median of 18.5 patients were recruited from each specialist (range 10-49).
The median age of patients was 59 years, 58% were female and half presented 78 days since their initial diagnosis. Over half were treated with curative intent (Table 1) . Patient understanding and denial were assessed at a median of 28 days (range 1-148 days) after treatment decisions were made. There were no significant a The items 'I seldom change the way I describe my cancer no matter who they are' and 'I seldom take unnecessary risks' were excluded from the analysis. b Items modified by replacing the words 'heart disease' with the word cancer'. differences in this time between patients seen by medical or radiation oncologists (P -0.13).
The majority of patients believed their oncologist supplied the most useful information and thought that it was clearly communicated ( Table 2 ). The proportion of patients who nominated their oncologist as a useful source of information varied from 50% to 86% across individual doctor's samples (X9 = 18.00, P -0.04).
Psychometric properties of the cardiac denial of impact scale
The psychometric properties of the Cardiac Denial of Impact Scale were explored since the measure had not been previously used with cancer patients. Factor analysis tested the assumption that the measure assessed a unidimensional construct. Two items had low correlations with other items (r's < 0.20) and were deleted from the scale [16] . Two factors which accounted for 63 percent of the variability in patient responses were extracted (Table 3) . Factor 1 described patient denial of 'fear about cancer' and factor 2, a non-specific response to illness, labelled 'generic denial'. Raw scores on items that loaded on these factors were summed to produce factor scores. The internal consistency of the 'fear about cancer' factor was high (Cronbach's alpha = 0.79, 17]. The inter-item reliability of 'generic denial' was low (0.49) and therefore this subscale was not considered in further analyses.
It can be hypothesised that patients who cope by using denial are less likely to seek information about their illness and under-utilise health services [18] . After adjusting for the effects of disease and patient characteristics, patients with relatively low denial of 'fear about cancer' scores were significantly more likely to have seen another doctor since last consulting their oncologist (OR = 1.10, 95% CI: 1.00-to 1.20, P = 0.04) and to have sought and nominated information from a State Cancer Council as useful (OR = 1.15, 95% CI: 1.02-1.30, P = 0.02), supporting the validity of this measure. Out of a possible score of 15, 50% of patients Table 4 . Patient understanding of disease extent. scored less than 8 on this scale, 25% less than 6 and 25% greater than 10.
Patient understanding of diagnosis and treatment type
All patients correctly reported their treatment regimen although 19 (8%; 95% CI: 4%-ll%) misunderstood their diagnosis. Four patients did not know the primary site of their tumour and another three did not understand that their disease had originated from an occult primary. A multivariate analysis was not performed as only a small number of patients failed to identify their diagnosis. However, univariate relationships between demographic and disease characteristics and patient understanding were demonstrated. Patients who misreported their diagnosis were significantly more likely to be male (63%, xi = 3.93, P = 0.05), relatively older (mean 64 vs. 56 years; t 2Ai = 2.37, P = 0.02) have metastatic cancer (63% vs. 34%, xi = 6.64, P = 0.01) be receiving palliative treatment (64%, \ 2 = 5.38, P -0.02) and believed to have no chance for cure (50%, x 2 = 6.39, P -0.04).
Patient understanding of disease extent
Overall, 71% (95% CI: 65%-77%) of patients correctly stated the extent of their cancer. Twenty-four percent (95% CI: 17%-30%) with localised disease believed their cancer was metastatic; almost half of these patients were receiving adjuvant therapies. Seventeen percent (95% CI: 9%-25%) with metastatic disease thought that their cancer was localised ( Table 4) .
The probability of treatment curing cancer was related to patients' understanding of disease extent (P = 0.03). Compared to patients with incurable disease (i.e., probability of cure 0%), those receiving treatments estimated by their doctors to give a l%-50% chance of cure were less likely to have correctly reported the extent of their disease (OR = 0.49, 95%: 0.23-1.02). Those with a greater than 50% chance were more likely to have understood this fact (OR = 1.16, 95% CI: 0.50-2.68).
Patient understanding of treatment intent
Sixty percent of patients (95% CI: 54%-67%) correctly stated the goal of treatment. Seventeen percent (95% CI: 10%-25%) receiving palliative therapies expected the treatment to either cure disease or prevent recurrence and 32% (95% CI: 21%-43%) with advanced disease receiving curative therapies believed their treatment was palliative ( Table 5 ). The chances of treatment curing disease significantly predicted understanding of treatment intent (P < 0.0001). In comparison with patients believed to have incurable disease, those with a l%-50% chance were less likely to have correctly reported this fact (OR = 0.79, 95% CI: 0.39-1.60), whereas those with more than a 50% chance were 7.76 times more likely to understand the intent of treatment (95% CI: 2.44-24.73). Patients who rated the information they had received as very clear were almost twice as likely to correctly identify the intent of treatment (OR = 1.93, 95% CI: 0.99-3.77, P = 0.05) compared with those who thought the information lacked clarity.
Patient understanding of the likelihood of achieving the goals of treatment: cure, prolongation of life and palliation
Only a few patients concurred with their doctors' estimates of the probability that treatment would cure disease (18%, 95% CI: 13%-23%), prolong life (13%, 95% CI: 8%-17%) or provide palliation (18%, 95% CI: 10%-27%). Forty-five percent (95% CI: 39%-51%) had optimistic expectations of cure with most overestimating their chances by more than 25% (Table 6 ). Forty-four percent (95% CI: 38%-51%) also overestimated the likelihood of treatment prolonging life. One-third (33%, 95% CI: 23%-43%) of patients receiving palliative treatments had optimistic expectations that treatment would achieve this aim. Approximately one third indicated that they did not know the chances of treatment curing cancer (30%, 95% CI: 25%-36%), prolonging life (29%, 95% CI: 23%-35%), or palliating disease (29%, 95% CI: 20%-39%).
Patients were more likely to have agreed with doctors' estimates of the likelihood of cure if they had relatively low levels of denial (OR = 2.20, 95% CI: 0.99-4.88, P = 0.05), if English was their first language (OR 4.33, 95% CI: 0.93-20.13, P = 0.03) and if they rated the information received as 'very clear' (OR = 2.18, 95% CI: 1.00-4.77, P = 0.05). The probability of cure also predicted understanding of this fact (P < 0.0001). Patients with a greater than 50% chance of being cured were more likely to correctly identify this fact (OR = 1.87, 95% CI: 0.78-4.46) when compared with those with incurable disease. However, those with a l%-50% chance of being cured were more likely to misunderstand this fact than patients with incurable disease (OR = 0.10, 95% CI: 0.03-0.38). Only gender predicted understanding of treatment prolonging life (P = 0.04) with males significantly less likely to correctly identify this fact (OR = 0.41, 95% CI: 0.26-1.03, P = 0.05).
Multivariate analyses could not be performed for patient understanding of the likelihood of treatment providing palliation since only 15 patients correctly identified this probability. Univariate analyses found that Australian-born patients were more likely to agree with doctors' estimates of this fact than those born overseas (33% vs. 9%, x 2 = 7.39, df = 1, P = 0.007), as did those who nominated more than one source of 'useful' information (36% vs. 10%, x 2 = 7.90, df = 1, P = 0.005), had achieved a higher educational status (32% vs. 12%, x 2 = 4.69, df = \,P = 0.02), and who rated the information they received from their oncologist as 'very clear' (29% vs. 10%, x 2 = 5.00, df = 1, P = 0.03). Inter-doctor differences were related to patient understanding of treatment palliating disease (x 2 = 13.83, df = 4, P = 0.008). The proportion of patients correctly identifying this fact ranged from 7% to 54% across the individual doctor samples. Caution should be exercised when interpreting these findings due to the small number of observations per cell.
Doctor disclosure of information and ability to detect patient understanding
Doctors believed that almost all patients understood their diagnosis and treatment type (96.4% and 99.6%, respectively) and thought that 60%, 52% and 77% understood the probability of treatment curing disease, prolonging life, and where relevant providing palliation, respectively. These results indicated a tendency for the doctors to over-estimate rates of understanding in their patients.
Doctors did not identify any patient who misunderstood their diagnosis or the goal of treatment and identified only two patients who misreported the extent of their disease. Doctors reported divulging these facts to over 95% of patients. Doctors identified 16% (95% CI: ll%-22%) of patients who misreported the probability of cure and 21% (95% CI: 15%-27%) who misunderstood the likelihood of treatment prolonging life. Four percent (95% CI: 0%-9%) of patients who inaccurately cited the chances of treatment palliating disease were identified.
Three doctors consistently failed to identify patients who misunderstood these facts. However, four were better at detecting misunderstanding but never more than half of cases. Doctors believed that 27 (12%; 95% CI: 8-16%) patients were not informed about their chances of cure and were unsure whether this information had been disclosed to a further 37 (16%, 95% CI: 11%-21%). The proportion of patients who were informed of their probability of being cured increased linearly with increasing likelihood of cure ( Xl = 13.00, P = 0.0003; Table 6 ). A linear trend was also evident for doctors' disclosure of the chances for prolonged survival (xi = 4.88, P = 0.03) but not for palliation.
Discussion
Our study suggests that patient understanding has improved over the last 10 years although significant gaps remain. We found that 17% of patients with metastatic disease believed that their cancer was localised and 17% receiving palliative therapy thought their treatment was curative in intent. Mackillop et al. [5] reported both these figures as 33% indicating a greater awareness of disease extent and treatment intent in today's cancer patients.
However, in accordance with earlier findings, patients in this study had difficulty in accurately reporting the chances of treatment achieving cure, prolongation of life and palliation, with most optimistically over-estimating or stating that they did not know their chances. Interestingly, patients in this study expressed optimistic views about prognosis even when correctly reporting that they had metastatic disease and were receiving palliative therapy. Modern day cancer patients may find this information unavoidable as detailed staging is usually performed before doctors make a treatment recommendation. However, doctors may disclose the extent of disease and intent of treatment in euphemistic terms without making explicit the implications of this information. One study with American physicians found that doctors prefer to stage information delivery and only disclose further details in response to patient questions [19] . This indicates that doctors provide basic information without elaborating on the prognostic implications of this information unless prompted by patients. Nonetheless, the optimistic reporting of understanding of facts by patients appears pervasive and may reflect a coping mechanism akin to denial.
Both denial of 'fear about cancer' and the probability of cure were significantly associated with patient understanding about the probability of treatment curing disease. Furthermore, patients' probability of cure was significantly associated with their understanding of disease extent and intent of treatment. These findings support the hypothesis that all patients find 'bad news' hard to accept, but that in addition, some patients have a greater tendency than others to screen out information that is particularly frightening. Such results are consis-tent with studies that report that patients who receive 'bad news' are less likely to utilise personalised communication aids such as audiotapes of and letters about oncology consultations [20, 21] . Guidelines for breaking bad news emphasise the need for doctors to take into account patients' ability to cope with potentially distressing information, suggesting that in some situations it may be inadvisable to provide detailed information to patients who use denial to cope [22] [23] [24] . Indeed, research has shown that providing detailed information increases distress in those patients who use avoidant coping styles [25] . Furthermore, when controlling for prognostic indicators, prospective cohort studies have demonstrated a significant association between denial-like responses and disease-free survival for patients with breast cancer [26, 27] . These findings underscore the importance of the doctor's role in maintaining what may be beneficial coping strategies and the risk that communicating distressing information poses to patients.
However, deliberately with-holding information has implications for informed consent and the empowerment of patients in treatment decision making. Weeks, Cook, O'Day et al. [8] found that patients with metastatic nonsmall-cell lung or colon cancers who optimistically estimated their prognoses were more likely to prefer and undergo aggressive therapy as opposed to palliative care but did not experience prolonged survival. The authors raised concerns that doctors who avoid communicating information about prognosis and/or who do not take steps to correct patient misunderstanding may deny patients their expert guidance and the opportunity to make decisions that will maximise quality of life. The doctors in our study indicated that they did not divulge prognostic information as commonly when the outlook was poor. Whether in response to patients' desire to avoid information or doctors' own difficulty with relaying negative news, this oversight may limit patients' ability to make informed decisions about treatment. It is important to acknowledge that denial may be a robust and resilient coping mechanism and therefore the fear that disclosing information inflicts psychological harm may be unfounded. Longitudinal studies are now required to assess the reciprocal effects of information provision on denial and evaluate the influence that denial and information-giving have on patient understanding and adjustment.
The results of this study suggest that informed consent and the process of shared decision making cannot necessarily or easily occur as part of a single event prior to the administration of treatment. Furthermore, the process may vary for different patients depending on their tendency to use denial as a coping mechanism. It is therefore important to determine whether denial remains static or is variable across the disease and treatment trajectory. In an earlier study, we demonstrated that patients' preferences for involvement in decision making and for information varied not only between patients but also within patients across time in response to changes in disease status [28] . It may therefore be important that dialogue about treatment is maintained and revisited throughout the course of the doctor-patient relationship.
We found that 24% of patients with localised disease believed they had metastatic cancer and one fifth of those receiving curative therapies thought their treatment was meant to palliate their illness. It may be that patients receiving adjuvant therapies and/or those who had a high likelihood of developing metastatic cancer recognised the uncertainty of the current known status of their disease. However, some patients may also pessimistically interpret information they are given. Responses to cancer other than denial, such as hoplelessness and fatalism identified by Watson et al. [29] , may also potentially influence patient comprehension and are therefore worthy of exploration in future research addressing the origins of misunderstanding. Although not assessed in this study, emotional states, such as anxiety may also affect understanding [30] and should also be assessed in future research.
Independent of patient denial, the quality of doctors' communication appears to impinge upon patients' capacity to understand medical details. Patient ratings of the clarity of the information received from oncologists were a significant determinant of their understanding of the intent of treatment and the probability for cure or palliation. These data support earlier findings that the comprehensibility of language, whether information is delivered in a structured manner and whether specific details are provided affect patient understanding [30] .
The doctors in this study also had difficulty identifying patient misunderstanding, typically under-estimating the proportion of patients misreporting information. These results suggest that doctors do not routinely assess patient understanding adding to the body of research demonstrating that most clinicians cannot accurately detect patient emotional states [31] . Together, these findings support the call for continuing medical education that has as its focus training in patient-centred communication skills.
Perhaps counter-intuitively, patients with incurable disease had a better understanding of disease extent, treatment intent and of the likelihood of cure than patients with a l%-50% chance of cure. However, it may be that an uncertain outcome gives patients greater scope for individual interpretation of information than a more certain one. In addition, doctors may have difficulty in communicating uncertainty to patients. This may be especially true for some patients with locally advanced disease who could be exposed to two messages: one, that cure is unlikely but possible and two, that risk of relapse is high and that therefore treatment is unlikely to be curative.
The use of the Cardiac Denial of Impact Scale in this sample yielded a psychometrically sound three-item measure defined as denial of fear about cancer. Although five of the items failed to demonstrate psychometric utility suggesting the limited applicability of a scale developed for cardiac patients in the cancer setting, the three-item measure appears to capture a coherent con-struct assessing the extent to which patients disavow the fear and concern about having cancer. However, it is likely that the denial measure used here does adequately reflect the experience of denial for all patients. Theoretical and empirical explications indicate that denial is a multidimensional construct with definitions distinguishing between maladaptive and adaptive forms of denial [32] . The former is said to be characterised by patient refusal to believe in the diagnosis, delays in seeking medical advice and treatment non-compliance [33] whilst adaptive denial is seen as the patient's attempt to minimise the emotional impact of the disease and may be effective in reducing psychological distress [34] . Maladaptive forms, in which patients refute the diagnosis itself are considered rare, so we chose to focus on a subtle and more common expression of denial. Greer [35] also distinguishes between three kinds of denial: denial of the diagnosis, of the implications of disease, and of the extent to which patients are distressed by their disease (the latter akin to the measure used in this study). Cognitive avoidance in which patients actively avoid information or thoughts about their disease is another variant [29] . Each of these definitions has varying implications for how patients understand and interpret information about their disease and for how doctors may challenge or deal with denial in their patients. The development of comprehensive measures of denial is welcomed to further describe the relationship between denial and patient understanding. Although not performed in this study, concurrent assessment of anxiety and denial may provide useful information about the validity of future measures given findings that patients' use of denial assists in maintaining emotional well-being [34] .
Methodological short-comings of the current study such as its reliance on doctor reports of the information communicated may limit the conclusions that can be drawn. However, this study is the first to investigate and demonstrate a relationship between patient denial and understanding. These results underscore the complexity of information exchange and human responses to frightening information. While it appears that patient denial plays a role in producing the misunderstanding reported above, doctors'ability to communicate effectively is also implicated. It is not yet clear whether denial can or should be confronted in order to maximise patient understanding. The challenge that oncologists face is how to communicate information in a manner which is both responsive to patients' emotional status and sufficiently informative to allow informed decision-making to take place.
